PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability CFFI Q1 2026 Earnings Solid EPS Performance Amid Modest Stock Decline Teradata Q1 2026 Earnings Strong EPS Surprise Driven by Profitability Focus IPAR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 SUUN Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Rally